The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran

Acta Microbiologica et Immunologica Hungarica

Volumn 56, Issue 1, 2009, Pages 89-99

  Bazzaz, Bibi Sedigheh Fazly ^a   Naderinasab, Mahboobeh ^b   Mohamadpoor, Amir Hooshang ^a   Farshadzadeh, Zahra ^b   Ahmadi, Samaneh ^a   Yousefi, Forough ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical isolate; Escherichia coli; Extended spectrum beta lactamase (ESBL); Klebsiella pneumoniae; Phenotypic confirmatory test; Prevalence

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENERAL HOSPITAL; HOSPITAL PATIENT; HUMAN; IRAN; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; OUTPATIENT; PHENOTYPE; PREVALENCE;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 63449131954     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.56.2009.1.7     Document Type: Article

References (45)

1. Vakulenko, S. B., Geryk, B., Kotra, L. P., Mobashery, Sh., Lerner, S. A.: Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene. Antimicrob Agents Chemother 42(7), 1542-1548 (1998).
2. Al-Jasser, A. M.: Extended spectrum beta-lactamases (ESBLs): a global problem. Kuwait Med J 38, 171-185 (2006).
3. Paterson, D. L., Bonomo, R. A.: Extended spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18, 657-686 (2005).
4. Shah, A. A., Hasan, F., Ahmed, S., Hameed, A.: Characteristics, epidemiology and clinical importance of emerging strains of gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol 155, 409-421 (2004).
5. Rodriguez-Bano, J., Paterson, D. L.: A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 42, 935-937 (2006).
6. Podschun, R., Uilmann, U.: Klebsiella species as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev 11, 589-603 (1998).
7. Chaudhary, U., Aggarwal, R.: Extended spectrum beta-lactamases: an emerging threat to clinical therapeutics. Indian J Med Microbiol 22(2), 75-80 (2004).
8. Reddy, P., Malczynski, M., Obias, A., Reiner, S., Jin, N., Huang, J., Noskin, G. A., Zembower, T.: Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 45, 846-852 (2007).
9. Rossolini, G. M., D'Andrea, M. M., Mugnaioli, C.: The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14, 33-41 (2008).
10. Piroth, L., Aubé, H., Doise, J. M., Vincent-Martin, M.: Spread of extended-spectrum betalactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27, 76-80 (1998).
11. Shivaprakasha, Sh., Radhakrishnan, K., Gireesh, A. R., Shamsul Karim, S. M.: Routine screening for ESBL production, a necessity of today. Int J Microbio 3 (2007).
12. Feizabadi, M. M., Etemadi, G., Yadegarinia, D., Rahmati M., Shabanpoor, Sh., Bokaei, S.: Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pnemoniae in Tehran. Med Sci Monit 12, 362-365 (2006).
13. Masjedian, F., Valehi, F., Talebi, A. A., Rastegar, Lari: Evaluation of wide broad spectrum antibiotic resistance of Escherichia coli and Klebsiella pneumoniae. IJMM 1(2), 27-34 (2007).
14. th ed. London (UK): Churchill Livingstone, pp. 361-413 (1996).
15. Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Jurek, M.: Antibiotic susceptibility testing by a standardized single method. Am J Clin Pathol 45, 493-496 (1996).
16. th ed. Approved standard M7-A7. CLSI, Wayne, PA (2006).
17. Goossens, H.: MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibility between countries and center types. J Antimicrob Chemother 46(Suppl T2), 39-52 (2000).
18. Andrews, J. M.: BSAC Working Party On Susceptibility Testing ft. BSAC standardized susceptibility testing method. J Antimicrob Chemother 48(Suppl S1), 43-57 (2001).
19. El-Khizzi, N. A., Bakheshwain, S. M.: Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 27(1), 37-40 (2006).
20. Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., Rahal, J. J.: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119(5), 353-358 (1993).
21. Karas, J. A., Pillay, D. G., Muckart, D., Sturm, A. W.: Treatment failure due to extendedspectrum beta-lactamase. J Antimicrob Chemother 37(1), 203-204 (1996).
22. Pagani, L., Migliavacca, R., Pallecchi, L., Matti, C., Giacobone, E., Amicosante, G., Romero, E., Mossolini, R. G.: Emerging extended-spectrum beta-lactamases in Proteus mirabilis. J Clin Microbiol 40(4), 1549-1552 (2002).
23. Jacoby, G. A., Han, P.: Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34, 908-911 (1996).
24. Bradford, P. A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951 (2001).
25. Stobberingh, E. E., Arends, J., Hoogkamp-Korstanje, J. A. A., Goessens, W. H. F., Visser, M. R., Buiting, A. G., Debets-Ossenkopp, Y. J., Ketel, R. J. van, Ogtrop, M. L. van, Sabbe, L. J., Voorn, G. P., Winter, H. L. J., Zeijl, J. H. van.: Occurrence of extended-spectrum betalactamases (ESBL) in Dutch Hospitals. Infection 27(6), 348-354 (1999).
26. Bell, J. M., Turnidge, J. D., Gales Pfaller, A. C. M. A., Jones, R. N.: Prevalence of extendedspectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 42, 193-198 (2002).
27. Hernández, J. R., Martínez-Martínez, L., Cantón, R., Coque, T. M., Pascual, A. and Spanish Group for Nosocomial Infections (GEIH): Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother 49(5), 2122-2125 (2005).
28. Ozgunes, I., Erben, N., Kiremitci, A., Kartal, E., Durmaz, G., Colak, H., Usluer, G., Colak, E.: The prevalence of extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J 27(5), 608-612 (2006).
29. Navon-Venezia, Sh., Hammer-Munz, O., Schwartz, D., Turner, D., Kuzmenko, B., Carmeli, Y.: Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clinic Microbiol 41(1), 155-158 (2003).
30. Menon, T., Bindu, D., Kumar, C. P. G., Nalini, S., Thirunarayan, M. A.: Comparison of double disc and three dimensional methods to screen for ESBL-producers in a tertiary care hospital. Indian J Med Microbiol 24(2), 117-120 (2006).
31. Khurana, S. N. M.: Extended-spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 116, 145-149 (2002).
32. Kumar, M. S., Lakshim, V., Rajagopalan, R.: Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. Isolated at a tertiary care institute. Indian J Med Microbiol 24(3), 208-211 (2006).
33. Kjerulf, A., Hansen, D. S., Sandvangm, D., Hansen, F., Frimodt-Mller, N.: The prevalence of ESBL-producing Escherichia coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS Feb 116(2), 118-124 18321362 (P,S,E,B,D) (2008).
34. Babay, H. A.: Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J 23, 186-190 (2002).
35. Coudron, P. E., Moland, E. S., Sanders, C. C.: Occurrence and detection of extended-spectrum beta-lactamase in members of Enterobacteriaceae of veterans Medical Center: Seek and You May Find. J Clin Microbiol 35, 2593-2597 (1997).
36. Bantar, C., Famiglietti, A., Goldberg, M.: Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 4, 85-90 (2000).
37. Selvakumar, B. N., Jasmin, R.: Antibiotic susceptibility of ESBL-producing urinary isolates at a tertiary care hospital in Tiruchirappalli, South India. J Med Sci 7(3), 443-446 (2007).
38. Mehrgan, H., Rahbar, M.: Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 31(2), 147-151 (2008).
39. Subha, A., Ananthan, S.: Extended spectrum beta-lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 20(2), 92-95 (2002).
40. Mushtaq, S., Hope, R., Warner, M., Livermore, D. M.: Activity of faropenem against cephalosporin-resistant Enterobacteriaceae. J Antimicrob Chemother 59(5), 1025-1030 (2007).
41. Kizirgil, A., Demirdag, K., Mehmet, O., Bulut, Y., Yakupogullari, Y., Toraman, Z. A.: In vitro activity of three different antimicrobial agents ESBL-producing Escherichia coli and Klebsiella pneumoniae blood isolates. Microbiol Res 160, 135-140 (2005).
42. Rice, L.: Evaluation and clinical importance of extended-spectrum beta-lactamase. Chest 119(2), 391-369 (2001).
43. Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., Fishman, N. O.: Epidemiological investigation of fluoroquinolone resistance in infections due to ESBL-producing Escherichia coli and K.penumoniae. Clin Infect Dis 33, 1288-1294 (2001).
44. Paterson, D. L., Mulazimoglu, L., Casellas, J. M., Ko, W. C., Goossens, H., GoHberg, A. von, Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormark, J. C., Yu, V. L.: Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum betalactamase production in Klebsiella pneumoniae isolates causing bactermia. Clin Infec Dis 30, 473-478 (2000).
45. Goyanes, M. J., Cercenado, E., Insa, R., Morente, A., Alcala, L.: Enterobacteriaceae: Comparative analysis between clinical isolates resistant and susceptible to third generation cephalosporins. Rev ESP Quimioterap 20(2), 216-221 (2007).